GNH USA

Europe — EMA

Nitromint (Glyceryl Trinitrate)

GNH USA supplies Nitromint (Glyceryl Trinitrate), a nitrate anti‑anginal agent for angina pectoris, acute coronary syndrome and heart failure.

Request sourcing

1
Pack/s

What is Glyceryl Trinitrate?

Glyceryl trinitrate, the active ingredient in Nitromint, is an organic nitrate presented as an oral preparation for oral use. It treats angina pectoris, acute coronary syndrome and heart failure by dilating coronary vessels and reducing myocardial oxygen demand. GNH USA supplies Nitromint as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Glyceryl Trinitrate used for?

Nitromint (glyceryl trinitrate) is employed in the management of ischemic heart conditions where nitric‑oxide mediated vasodilation is required.

Angina pectoris: provides rapid relief of chest pain by dilating coronary arteries. Acute coronary syndrome: improves myocardial perfusion during unstable episodes. Heart failure: reduces preload and afterload, easing cardiac workload.

What are the side effects of Glyceryl Trinitrate?

Nitromint may cause a range of adverse reactions, most of which are dose‑related and transient.

Common Side Effects: - Headache: throbbing or pressure‑type pain. - Flushing: warmth and redness of the face or neck. - Dizziness or light‑headedness, especially on standing. - Hypotension: mild drop in blood pressure. - Nausea: occasional upset stomach. - Palpitations: awareness of heartbeat.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Reflex tachycardia: rapid heart rate in response to vasodilation. - Methemoglobinemia: abnormal hemoglobin affecting oxygen delivery. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Syncope: fainting episodes. - Chest pain worsening: paradoxical increase in angina.

What precautions apply to Glyceryl Trinitrate?

Before prescribing Nitromint, clinicians should consider patient‑specific factors and monitor for potential complications.

Avoid use in patients with known hypersensitivity to organic nitrates. Monitor blood pressure regularly, especially after dose initiation. Caution in patients with severe anemia or elevated intracranial pressure. Do not combine with phosphodiesterase‑5 inhibitors due to risk of profound hypotension. Educate patients on orthostatic precautions to prevent dizziness. Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

What does Glyceryl Trinitrate interact with?

Nitromint can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): may cause severe hypotension. - Other nitrates or nitrites: additive vasodilatory effect leading to dangerous blood pressure drops.

Moderate Interactions (Monitor Closely): - Antihypertensives (e.g., ACE inhibitors, beta‑blockers): may enhance blood‑pressure‑lowering effect. - Diuretics: can potentiate orthostatic hypotension. - Alcohol: may increase vasodilatory response and dizziness. - Certain antiretrovirals (e.g., protease inhibitors): may affect nitrate metabolism.

Frequently asked questions

What is Nitromint used for?+
Nitromint contains glyceryl trinitrate, an organic nitrate that is prescribed to relieve angina pectoris, manage acute coronary syndrome, and support treatment of heart failure by dilating coronary vessels and reducing cardiac workload.
How does glyceryl trinitrate work in the body?+
After oral administration, glyceryl trinitrate is converted to nitric oxide within vascular smooth muscle. Nitric oxide activates guanylate cyclase, raising cyclic GMP levels, which relaxes smooth muscle, causing venous and arterial dilation and lowering myocardial oxygen demand.
What is the usual dose of Nitromint?+
The appropriate dose of Nitromint is determined by the prescribing clinician based on the individual’s clinical condition, severity of symptoms, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.
Is Nitromint safe during pregnancy or breastfeeding?+
Safety data for glyceryl trinitrate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.
How do I order Nitromint from GNH USA?+
To request Nitromint, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Nitromint compare with other anti‑anginal drugs?+
Nitromint (glyceryl trinitrate) belongs to the organic nitrate class, offering rapid onset of vasodilation. Compared with beta‑blockers or calcium‑channel blockers, nitrates act directly on vascular smooth muscle and are often used for acute symptom relief or as adjunct therapy.
What are the storage requirements for Nitromint?+
Nitromint should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and sources of heat to maintain stability.
How is Nitromint administered?+
Nitromint is taken orally as directed by a healthcare professional. The tablet (or other oral form) is swallowed with water, and patients should avoid crushing or chewing unless specifically instructed.
What are the most serious risks associated with Nitromint?+
The most serious risks include severe hypotension, reflex tachycardia, and rare cases of methemoglobinemia. Patients should seek immediate medical attention if they experience fainting, chest pain that worsens, or signs of an allergic reaction.
Who should not use Nitromint?+
Nitromint is contraindicated in individuals with known hypersensitivity to organic nitrates, those taking phosphodiesterase‑5 inhibitors, or patients with severe anemia, increased intracranial pressure, or uncontrolled hypotension. Clinicians should evaluate each patient’s medical history before prescribing.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Glyceryl Trinitrate
Route
Oral Use
Manufacturer
Egis Pharmaceuticals Plc
Origin
EU

Related products